SPONSOR
National Cancer Institute, Naples
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 3
Conditions studied: Colorectal Cancer MetastaticColorectal Cancer (CRC)Advanced or Metastatic Gastrooesophageal CarcinomaColorectal Cancer Stage IVHepatocellular CarcinomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the AnusPatient Satisfaction and Efficacy of Bowel-preparationColon Cancer Prevention
National Cancer Institute, Naples is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Advanced or Metastatic Gastrooesophageal Carcinoma, Colorectal Cancer Stage IV.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Cancer Institute, Naples
How many clinical trials has National Cancer Institute, Naples sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by National Cancer Institute, Naples, of which 7 are actively recruiting participants. These trials cover conditions including Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Advanced or Metastatic Gastrooesophageal Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Cancer Institute, Naples research focus on?
National Cancer Institute, Naples clinical trials span Colorectal Cancer Metastatic, Colorectal Cancer (CRC), Advanced or Metastatic Gastrooesophageal Carcinoma, Colorectal Cancer Stage IV, Hepatocellular Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Cancer Institute, Naples clinical trial?
To participate in a National Cancer Institute, Naples trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Cancer Institute, Naples trials with current recruitment status updated daily.
Clinical Trials by National Cancer Institute, Naples
NCT07213570 Phase 2
Recruiting
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
Colorectal Cancer Metastatic
NCT06886282
Recruiting
Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease
Colorectal Cancer (CRC)
NCT07213557 Phase 2
Recruiting
Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy
Advanced or Metastatic Gastrooesophageal Carcinoma
NCT06509126 Phase 3
Recruiting
Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
Colorectal Cancer Stage IV
NCT06905262
Recruiting
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
Hepatocellular Carcinoma
NCT06236464
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Squamous Cell Carcinoma of the Head and Neck
NCT06887244
Recruiting
Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity
Patient Satisfaction and Efficacy of Bowel-preparation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology